Status:
COMPLETED
The Remote Monitoring of Gout Feasibility Study
Lead Sponsor:
Diakonhjemmet Hospital
Conditions:
Gout
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
In this feasibility trial, a digital follow-up treatment strategy with patient self-management app (Urika) and remote monitoring in specialist healthcare for patients with gout will be tested.
Detailed Description
In this feasibility study various outcome measures will be assessed to determine whether the app (Urika) is viable, practical, and useful. The study will include assessments of technical, operational,...
Eligibility Criteria
Inclusion
- Male or non-pregnant, non-nursing female \>18 years of age at screening
- Patients with a clinical diagnosis of gout
- Patients who fulfil the American College of Rheumatology (ACR)/EULAR classification criteria
- Serum urate level \>360 μmol/L at inclusion
- Having a smartphone/tablet
Exclusion
- Contraindication for urate lowering therapy
- Unstable medical conditions (e.g,, uncontrollable hypertension, impaired liver function); known stage 3b or higher chronic kidney disease (estimated glomerular filtration (eGFR) rate/creatinine clearance \<45 mL/min); severe infection or gastrointestinal bleed
- Major co-morbidities (e.g., malignancies, severe cardiovascular disease, severe diabetes mellitus, severe respiratory diseases)
- Psychiatric or mental disorders, alcohol abuse or other substance abuse, language barriers or other factors which makes adherence to the study protocol difficult
Key Trial Info
Start Date :
February 27 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 11 2024
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT06211322
Start Date
February 27 2024
End Date
October 11 2024
Last Update
December 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diakonhjemmet Hospital
Oslo, Norway, 0319